Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Alizapride
2. Alizapride Hydrochloride
3. Litican
4. Ms 5080
5. Ms-5080
6. N-((1-allyl-2-pyrrolidinyl)methyl)-6-methoxy-1h-benzotriazole-5-carboxamide
7. N-((allyl-1-pyrrolidinyl-2)-methyl)methoxy-2-azimido-4,5-benzamide
8. N-(1-allyl-2-pyrrolidinylmethyl)-6-methoxy-1h-benzotriazole-5-carboxamide Hydrochloride
9. Plitican
1. 59338-87-3
2. Limican
3. 41bt72boq7
4. Plitican
5. Nausilen
6. 6-methoxy-n-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1h-1,2,3-benzotriazole-5-carboxamide Hydrochloride
7. Pliyivsn
8. Alizaprid Hydrochlorid
9. Unii-41bt72boq7
10. Hy-a0125a
11. Dtxsid20974759
12. Alizapride Hydrochloride [mi]
13. Ac-6819
14. Alizapride Hydrochloride [mart.]
15. Alizapride Hydrochloride [who-dd]
16. Cs-0019741
17. Q27258431
18. N-(1-allyl-2-pyrrolidinylmethyl)-6-methoxy-1h-benzotriazole-5-carboxamide Hydrochloride
19. (+/-)-n-(1-allyl-2-pyrrolidinylmethyl)-6-methoxy-1h-benzotriazole-5-carboxamide Hydrochloride
20. 1h-benzotriazole-5-carboxamide, 6-methoxy-n-((1-(2-propenyl)-2-pyrrolidinyl)methyl)-, Monohydrochloride
21. 1h-benzotriazole-5-carboxamide,6-methoxy-n-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-, Monohydrochloride
22. 5-methoxy-n-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1h-benzotriazole-6-carboximidic Acid--hydrogen Chloride (1/1)
23. 6-methoxy-n-((1-(2-propen-1-yl)-2-pyrrolidinyl)methyl)-1h-benzotriazole-5-carboxamide Hydrochloride
Molecular Weight | 351.8 g/mol |
---|---|
Molecular Formula | C16H22ClN5O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 351.1462027 g/mol |
Monoisotopic Mass | 351.1462027 g/mol |
Topological Polar Surface Area | 83.1 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 433 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Global Sales Information
Market Place
ABOUT THIS PAGE
A Alizapride Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alizapride Hydrochloride, including repackagers and relabelers. The FDA regulates Alizapride Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alizapride Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alizapride Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alizapride Hydrochloride supplier is an individual or a company that provides Alizapride Hydrochloride active pharmaceutical ingredient (API) or Alizapride Hydrochloride finished formulations upon request. The Alizapride Hydrochloride suppliers may include Alizapride Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Alizapride Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Alizapride Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alizapride Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alizapride Hydrochloride GMP manufacturer or Alizapride Hydrochloride GMP API supplier for your needs.
A Alizapride Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Alizapride Hydrochloride's compliance with Alizapride Hydrochloride specifications and serves as a tool for batch-level quality control.
Alizapride Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Alizapride Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alizapride Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Alizapride Hydrochloride EP), Alizapride Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alizapride Hydrochloride USP).
LOOKING FOR A SUPPLIER?